ArticleEC psychology and psychiatry2018

Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

Kenneth Blum et al.PubMed ↗Full text ↗

No numbers read from the abstract.